Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Side effects of verapamil in infants.

Literature DB >> 6859944

Side effects of verapamil in infants.

Abstract

Two infants with supraventricular tachycardia were given intravenous verapamil and subsequently suffered life threatening bradycardia and hypotension. As there were no predisposing factors, direct drug action is implicated and other reports of the adverse effects of verapamil are noted. Supraventricular tachycardia in neonates and young infants may be safely treated with digoxin and cardioversion, and intravenous verapamil should be avoided.

Entities: Chemical Disease Species

Mesh：

Substances：
Verapamil

Year: 1983 PMID： 6859944 PMCID： PMC1627995 DOI： 10.1136/adc.58.6.465

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

7 in total

1. Verapamil in cardiology.

Authors: D Krikler
Journal: Eur J Cardiol Date: 1974-08

2. Effects of verapamil on supraventricular tachycardia in children.

Authors: C J Porter; P C Gillette; A Garson; P S Hesslein; P P Karpawich; D G McNamara
Journal: Am J Cardiol Date: 1981-09 Impact factor: 2.778

3. Verapamil and PSVT.

Authors: E G Abinader; A Berger
Journal: Circulation Date: 1979-11 Impact factor: 29.690

4. [Acute treatment with verapamil of paroxysmal supraventricular tachycardia and atrial flutter in paediatric age (author's transl)].

Authors: B Musto; R Greco; R Calabrò; F Marsico
Journal: G Ital Cardiol Date: 1979

5. Effect of verapamil in infants with paroxysmal supraventricular tachycardia.

Authors: J Soler-Soler; J Sagristá-Sauleda; A Cabrera; J Sauleda-Parés; J Iglesias-Berengué; G Permanyer-Miralda; J Roca-Llop
Journal: Circulation Date: 1979-05 Impact factor: 29.690

6. Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children.

Authors: E Shahar; Z Barzilay; M Frand
Journal: J Pediatr Date: 1981-02 Impact factor: 4.406

7. Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate, and verapamil: a comparative study.

Authors: R Greco; B Musto; V Arienzo; A Alborino; S Garofalo; F Marsico
Journal: Circulation Date: 1982-09 Impact factor: 29.690

7 in total

12 in total

Review 6. Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors: D McTavish; E M Sorkin
Journal: Drugs Date: 1989-07 Impact factor: 9.546

Review 7. Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors: D Faulds; P Chrisp; M M Buckley
Journal: Drugs Date: 1991-04 Impact factor: 9.546

8. Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children.

Authors: J A Soult; M Muñoz; J D Lopez; A Romero; J Santos; A Tovaruela
Journal: Pediatr Cardiol Date: 1995 Jan-Feb Impact factor: 1.655

Review 9. Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors.

Authors: C Steinberg; D A Notterman
Journal: Clin Pharmacokinet Date: 1994-11 Impact factor: 6.447

10. Supraventricular tachycardia in infants: response to initial treatment.

Authors: N Sreeram; C Wren
Journal: Arch Dis Child Date: 1990-01 Impact factor: 3.791